226 related articles for article (PubMed ID: 35487055)
1. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach.
Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK
Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055
[TBL] [Abstract][Full Text] [Related]
2. Novel combination therapy of prostate cancer cells with arsenic trioxide and flutamide: An in-vitro study.
Mirzaei A; Akbari MR; Tamehri Zadeh SS; Khatami F; Mashhadi R; Aghamir SMK
Tissue Cell; 2022 Feb; 74():101684. PubMed ID: 34800879
[TBL] [Abstract][Full Text] [Related]
3. The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell lines.
Rezaeian A; Khatami F; Heidari Keshel S; Akbari MR; Mirzaei A; Gholami K; Mohammadi Farsani R; Aghamir SMK
Sci Rep; 2022 Dec; 12(1):20924. PubMed ID: 36463254
[TBL] [Abstract][Full Text] [Related]
4. Combined anticancer effects of simvastatin and arsenic trioxide on prostate cancer cell lines via downregulation of the VEGF and OPN isoforms genes.
Mirzaei A; Rashedi S; Akbari MR; Khatami F; Aghamir SMK
J Cell Mol Med; 2022 May; 26(9):2728-2740. PubMed ID: 35366048
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21(WAF1/CIP1) expression via epigenetic remodeling in LNCaP and PC3 cell lines.
Jadhav V; Ray P; Sachdeva G; Bhatt P
Life Sci; 2016 Mar; 148():41-52. PubMed ID: 26883975
[TBL] [Abstract][Full Text] [Related]
6. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.
Khosravani F; Amiri F; Mahmoudi R; Morshedi D; Kobarfard F; Alipour M; Hosseini E; Bardania H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2347-2357. PubMed ID: 37831114
[TBL] [Abstract][Full Text] [Related]
7. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer.
Deng ZT; Liang SF; Huang GK; Wang YQ; Tu XY; Zhang YN; Li S; Liu T; Cheng BB
J Integr Med; 2024 May; 22(3):295-302. PubMed ID: 38599914
[TBL] [Abstract][Full Text] [Related]
8. RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.
Kumagai T; Ikezoe T; Gui D; O'Kelly J; Tong XJ; Cohen FJ; Said JW; Koeffler HP
Clin Cancer Res; 2004 Feb; 10(4):1508-20. PubMed ID: 14977855
[TBL] [Abstract][Full Text] [Related]
9. Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells.
Cai X; Cai X; Wang C; Chen B; Hua W; Shen F; Yu L; He Z; Shi Y; Chen Y; Xia G; Bao W; Zhang Y; Wang X
J Biomed Nanotechnol; 2014 Feb; 10(2):251-61. PubMed ID: 24738333
[TBL] [Abstract][Full Text] [Related]
10. Additive antitumor effect of arsenic trioxide combined with intravesical bacillus Calmette-Guerin immunotherapy against bladder cancer through blockade of the IER3/Nrf2 pathway.
Mao MH; Huang HB; Zhang XL; Li K; Liu YL; Wang P
Biomed Pharmacother; 2018 Nov; 107():1093-1103. PubMed ID: 30257321
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells.
Byun JM; Lee DS; Landen CN; Kim DH; Kim YN; Lee KB; Sung MS; Park SG; Jeong DH
Acta Oncol; 2019 Nov; 58(11):1594-1602. PubMed ID: 31257975
[No Abstract] [Full Text] [Related]
12. Curcumin combined with arsenic trioxide in the treatment of acute myeloid leukemia: network pharmacology analysis and experimental validation.
Zeng YJ; Liu F; Wu M; Wu XP; Zhang DL; Yuan QQ; Zhou L; Wu ZH
J Cancer Res Clin Oncol; 2023 Jan; 149(1):219-230. PubMed ID: 36352148
[TBL] [Abstract][Full Text] [Related]
13. Low dosage of arsenic trioxide (As
Luo D; Zhang X; Du R; Gao W; Luo N; Zhao S; Li Y; Chen R; Wang H; Bao Y; Yang W; Liu D; Shen W
J Biol Inorg Chem; 2018 Aug; 23(6):939-947. PubMed ID: 30014256
[TBL] [Abstract][Full Text] [Related]
14. MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53.
Wang YS; Yin JZ; Shi XQ; Zhao XW; Li B; Yang MH
Anticancer Agents Med Chem; 2023; 23(16):1829-1837. PubMed ID: 37259217
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells.
Sun Y; Wang C; Wang L; Dai Z; Yang K
Cell Mol Biol Lett; 2018; 23():13. PubMed ID: 29610575
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
Maeda H; Hori S; Ohizumi H; Segawa T; Kakehi Y; Ogawa O; Kakizuka A
Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
[TBL] [Abstract][Full Text] [Related]
17. [CircRNA-0028171 regulates arsenic trioxide-induced apoptosis in vascular endothelial cells].
Wu JC; Jin SD; Song JH; Liu XQ; Ma WJ; Chang L; Guan XX; Zhang MY; Liu JQ; Fu H; Wang Y; Xu CQ
Sheng Li Xue Bao; 2022 Oct; 74(5):763-772. PubMed ID: 36319099
[TBL] [Abstract][Full Text] [Related]
18. Novel Combination of Arsenic Trioxide (As
Yen CM; Tsai CW; Chang WS; Yang YC; Hung YW; Lee HT; Shen CC; Sheu ML; Wang JY; Gong CL; Cheng WY; Bau DT
Cancer Genomics Proteomics; 2018; 15(6):453-460. PubMed ID: 30343279
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of arsenic trioxide (As2O3) on cervical cancer in vitro and in vivo through apoptosis induction.
Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
Cancer Biol Ther; 2007 Apr; 6(4):580-6. PubMed ID: 17374990
[TBL] [Abstract][Full Text] [Related]
20. Study of As
Zhu Y; Chen W; Guan W; Fang Y; Hao C
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1932-1937. PubMed ID: 31079498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]